Key Highlights

  • The Elmet Group (ELMT) shares fell 11.19% to $17.66, giving back part of a near-19% surge as short interest climbed to about 9.3% of float.
  • Second-quarter Revenue grew 35.2% year-over-year to $66.4 million, with a record open order Backlog of $131.5 million, up 55% from a year earlier.
  • The company swung to a GAAP net loss of $4.5 million, though adjusted Net Income was positive at $5.2 million, aided by IPO-related one-time items.
  • Elmet was awarded a $4.3 million U.S. Department of War contract for molybdenum component development and was added to the Russell 3000 and Russell Microcap indexes.

The Elmet Group Co. (NASDAQ:ELMT) shares fell 11.19% to $17.66 in the latest closing session, placing the stock among the day's most notable decliners.

What Happened

The Elmet Group Co. (ELMT) shares fell 11.19% to $17.66 in the latest closing session, a sharp pullback following an even sharper rally.

The Latest Company Catalyst

The most concrete recent catalyst is Elmet's second-quarter 2026 Earnings report, released August 13. Revenue grew 35.2% year-over-year to $66.4 million, driven by strong Demand from the aerospace, defense, and government (AD&G) end markets. Gross Margin expanded 430 basis points to 25.0%, and the company's open order backlog reached a record $131.5 million, up 55% from the prior-year quarter.

Separately, reporting around the same period noted Elmet had increased its ownership stake in critical-materials producer EQ Resources Limited to help secure its tungsten Supply chain, deployed 3D Systems metal additive Manufacturing equipment for hypersonic aerospace components, and was awarded a $4.3 million contract from the U.S. Department of War for molybdenum component development. The company was also added to the Russell 3000 and Russell Microcap indexes, a technical event that can drive passive-fund buying and, later, selling as positioning normalizes.

Financial Position

Despite the strong top-line growth, Elmet swung to a net loss of $4.5 million, or $0.16 per share, in the second quarter, compared with net income of $1.2 million a year earlier. On an adjusted basis, the company reported net income of $5.2 million, or $0.18 per share, suggesting the GAAP loss was influenced by one-time or non-cash items tied to becoming a public company.

The IPO materially strengthened the balance sheet: cash rose to $66.1 million at quarter-end from just $1.8 million at the end of 2025, and long-term Debt was reduced meaningfully following paydown from IPO proceeds. Trailing twelve-month revenue stands at approximately $228.5 million, up about 20% year-over-year, with a market Capitalization near $540 million following the recent pullback. No forward earnings guidance has been issued.

The Investment Story

Elmet positions itself as a critical-materials and precision-manufacturing supplier serving aerospace, defense, and industrial customers, with exposure to tungsten, molybdenum, and other refractory metals that are increasingly viewed as strategically important amid supply-chain security concerns and elevated defense spending. The record backlog and accelerating revenue growth support a bullish long-term narrative, and analyst coverage initiated around the IPO has generally carried Buy or Overweight ratings with price targets clustered near $20-21.

The bear case centers on execution risk typical of newly public companies: the swing to a GAAP net loss, a still-unproven track record as a public reporting entity, and a valuation that, at roughly 2.4 times trailing sales, leaves little room for disappointment if growth decelerates or margins compress.

What Could Be Worrying Investors

The stock's own volatility, a near-19% surge followed by a double-digit drop within a week, is consistent with technical profit-taking after a sharp, possibly overextended rally, particularly in a stock with a relatively small public float. Short interest has been climbing, reaching about 9.3% of float as of late July, up from roughly 8.2% two weeks earlier, indicating growing bearish positioning that can amplify swings in either direction.

The shift from net income to a net loss, even with a plausible adjusted-earnings explanation, may be prompting some investors to reassess near-term profitability. As a company that IPO'd in April, Elmet may be approaching typical post-IPO lock-up expiration windows, a period historically associated with increased insider share availability and downward price pressure, though no specific lock-up-related filing was confirmed in available reporting.

What Investors Should Watch Next

Investors should watch for the company's third-quarter 2026 earnings report, expected in the November timeframe, for evidence that backlog conversion and margin expansion are continuing. Any insider selling activity or Form 4 filings following a potential lock-up expiration would be worth monitoring given the elevated short interest.

Additional contract awards or expansions tied to defense and critical-materials supply-chain initiatives, similar to the recent Department of War molybdenum award, could serve as positive catalysts. Trends in short interest and days-to-cover data will help gauge whether bearish positioning is building or unwinding.

A Record Backlog Meets a Post-IPO Reset

The Elmet Group's stock decline appears best understood as a sharp pullback following an even sharper rally, set against a backdrop of genuinely strong revenue growth, a record backlog, and strategic positioning in critical materials for aerospace and defense, offset by a swing to a GAAP net loss and rising short interest.

With only four months of trading history as a public company, ELMT remains a name where price action can diverge meaningfully from underlying fundamentals in the near term. Investors should weigh the company's improving backlog and margin trends against its limited public track record and ongoing profitability questions.